Select Location
What is your delivery location?
We need your delivery location to continue browsing
Select Location
We need your delivery location to continue browsing
Prescription Required
novartis
30x1 tablet
Sonidegib
Keep in cold place
Delivering To:
Overview
Odomzo 200mg Capsule is a prescription medication used to treat adults with advanced basal cell carcinoma, a type of skin cancer. It works by targeting an enzyme called an agonist, which stimulates the growth of tissues in the affected area. This medicine belongs to a class of medications known as Hedgehog pathway inhibitors and is usually taken once daily for 8 weeks or until the tumor becomes smaller in size.
Skin Cancer
Odomzo 200mg Capsule is a hedgehog pathway inhibitor used to treat patients with locally advanced, recurrent, and metastatic basal cell carcinoma in adults. Its primary effect lies in blocking activity from the Smoothened protein, an important component of the hedgehog cellular signaling pathway involved in maintaining homeostasis within cells. This causes these cells to die off or stop growing, helping to reduce tumor size and prevent it from spreading further. Odomzo Capsule does not, however, affect other types of normal cells, making it a less aggressive treatment than many other anti-cancer therapies available today.
One of the most common side effects of Odomzo 200mg Capsule is gastrointestinal issues. Because many of the metabolized forms of the drug are released through the patient’s digestive system, they may experience nausea, vomiting, and diarrhea. Patients may also notice a decrease in their appetite and weight while they’re on the medication, so doctors may prescribe additional dietary supplements to ensure they’re getting the nutrients they need.
When taking any type of medication, it is important to follow your healthcare provider's instructions to ensure the best possible outcome. With Odomzo Capsule, this means taking one 200 mg tablet every day with or without food. Generally, it is recommended that people take sonidegib at the same time every day, preferably in the morning. It should also be noted that it can take several weeks before it is possible to start feeling the effects of sonidegib, so it is important to continue taking the medication regularly despite any persistent symptoms.
Alcohol
unsafe
It is advisable not to consume alcohol while taking this medicine.It is advisable not to consume alcohol while taking this medicine.
Pregnancy
consult your doctor
Do not take Odomzo 200mg Capsule without consulting the doctor, in case of pregnancy.
Breast Feeding
consult your doctor
Without a doctor's consultation, do not take this medicine if you're breastfeeding.
Driving
danger
It is advisable not to drive or operate heavy machinery, you may feel dizzy as one of the side effects of the medicine.
Kidney
caution
Do not take Odomzo 200mg Capsule without a doctor's consultation in case of kidney problems.
Liver
caution
Share your medical history with the doctor in case of liver disease before taking this medicine.
If you miss any dose of Odomzo 200mg Capsule, consult your doctor. Do not take twice the dose to catch up on the missed one. This will cause severe side effects and impact your overall health and duration of treatment.
Some studies have suggested that the Odomzo Capsule may have some level of cytotoxic effects in vitro, but there is still no solid evidence to show that this is the case. Therefore, more research needs to be done before we can definitively know whether or not the Odomzo Capsule is indeed cytotoxic.
Odomzo is a prescription medication that is used to treat adults with basal cell carcinoma - a rare skin cancer. Odomzo is applied topically, directly to the site of the tumor, and is typically used after surgery or radiation treatments have failed
Odomzo is a medication that works by inhibiting the action of a specific protein, known as smoothened (SMO). By blocking the action of SMO with Odomzo, abnormal cell growth can be stopped.
Odomozo is supposed to be taken 1 hr before meals or two hours after meals but is generally preferred on an empty stomach.
Then discuss it with the doctor immediately so as to avoid facing further complications or side effects associated with this medicine.
novartis
Written By
Venika Choudhary
Medical Content Writer @ Magicine Pharma
I hold an M.Sc. in Microbiology and have a strong academic foundation in microbial sciences and applied biotechnology. I began my career with extensive hands-on research at CSIR laboratories, focusing on fungal enzyme production, studying fungal diversity in various ecosystems, and developing bio-pesticides as sustainable alternatives to chemical pesticides. This work deepened my understanding of fungal biology, bioactive compounds, and their pharmaceutical and agricultural applications. Transitioning from research, I now work as a medical content writer, where I combine my scientific expertise with a passion for clear and reliable healthcare communication. I apply my research background to create patient-friendly, compliant content for pharmaceutical companies and healthcare platforms, ensuring science is both trustworthy and accessible. Specializing in clear, accurate, and engaging content, I help patients make informed decisions and support pharmaceutical companies in delivering trusted information. Whether writing product descriptions, crafting disease awareness articles, or composing drug information leaflets, I consistently meet regulatory standards and address audience needs, making my content an asset for healthcare brands.
Reviewed By
Dr. Aditya Sarin - MBBS, MD, DrNB - Consultant Medical Oncology
Dr. Aditya Sarin, MBBS, MD, DrNB, is a highly qualified medical oncologist with profound research and clinical expertise, currently working at Sir Ganga Ram Hospital, New Delhi. He is also a member of the European Society of Medical Oncology (ESMO), a non-profit European organization dedicated to eradicating cancer by promoting comprehensive cancer care and advancing medical oncology. He has been honored with several awards, including the International Cancer Foundation scholarship (ESMO congress, 2022) and Young Medical Oncologist of the Year (Times of India, 2024). He is well-known for his breakthrough in oncology. Dr. Sarin is passionate about converting complex health information into a concise and clear form that is understandable to everyone, aiming to create awareness and cancer care among people.